Scarica l'app Stockscreener
194.36
1.39%
-2.74
Dopo l'orario di chiusura:
190.54
-3.82
-1.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$197.10
Aprire:
$197
Volume 24 ore:
961.94K
Relative Volume:
1.11
Capitalizzazione di mercato:
$12.47B
Reddito:
$13.84B
Utile/perdita netta:
$1.10B
Rapporto P/E:
18.66
EPS:
10.4185
Flusso di cassa netto:
$1.49B
1 W Prestazione:
-2.10%
1M Prestazione:
+27.88%
6M Prestazione:
+62.40%
1 anno Prestazione:
+42.57%
Intervallo 1D:
$193.86
$197.09
Intervallo di 1 settimana:
$193.76
$199.49
Portata 52W:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Nome
Davita Inc
Settore
Industria
Telefono
310-536-2668
Indirizzo
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
194.36 | 12.65B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
378.54 | 85.27B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
175.32 | 14.92B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
21.57 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.85 | 10.45B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Davita Inc Borsa (DVA) Ultime notizie
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): shares trade sideways ahead of next earnings as valuation comes in - AD HOC NEWS
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Two Sides of the "Gift of Life" From DaVita Teammates - ACCESS Newswire
DaVita and Arcosa have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
DaVita Stock Is Up 70% YTD: What the Numbers Say About 2026 - TIKR.com
Bull of the Day: DaVita Inc. (DVA) - Zacks Investment Research
Hope in our Hometown: DaVita Celebrates the 2026 Transplant Games in Denver - DaVita Newsroom
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Best Growth Stocks to Buy for May 26th - The Globe and Mail
Zacks.com featured highlights include DaVita, Integra LifeSciences, Braskem and LyondellBasell - Yahoo Finance
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Navigating Growth in Healthcare with Strong ROE and Strategic Positioning - DirectorsTalk Interviews
DaVita stock (US23918K1088): dialysis giant faces regulatory overhang after strong rally - AD HOC NEWS
What DaVita (DVA)'s 2030 Community Care Goals and Upgraded Outlook Mean For Shareholders - Yahoo Finance
DaVita Honors 57 DAISY Nurses As Investors Weigh Workforce And Valuation - Yahoo Finance
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
DaVita stock (US23918K1088): Q4 2025 revenue beat and debt load stay in focus - AD HOC NEWS
DaVita Honors Extraordinary Nurses With the 2026 DAISY Awards - ACCESS Newswire
Beyond the Clinical: How Social Workers Drive Kidney Transplant Success - DaVita Newsroom
DaVita stock (US23918K1088): solid Q1 2025 earnings keep dialysis specialist in focus - AD HOC NEWS
DaVita Inc stock (US23804L1035): earnings, buyback and outlook after strong first quarter - AD HOC NEWS
AI shows promise as health systems invest in chronic disease tech - Modern Healthcare News
DaVita ESG Roadmap Links 2030 Care Goals To Core Operations - Yahoo Finance
DaVita’s SWOT analysis: healthcare stock faces growth amid volatility By Investing.com - Investing.com South Africa
DaVita’s SWOT analysis: healthcare stock faces growth amid volatility - Investing.com
DaVita Inc. Lifts Outlook After Q1 Earnings Beat - TipRanks
DaVita stock (US23918K1088): Insider sale follows strong Q1 2026 earnings - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Best Value Stocks to Buy for May 19th - Yahoo Finance Australia
DaVita stock (US23918K1088): solid Q1 2026, buyback boost and kidney care focus - AD HOC NEWS
Davita chief compliance officer James Hearty sells $2.9m in stock - Investing.com India
DaVita Inc (DVA) Stock Price, Trades & News - GuruFocus
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals - PR Newswire
Zacks.com featured highlights include DaVita, Antero Resources, PBF Energy and Popular - Yahoo Finance Singapore
DaVita stock (US23918K1088): dialysis provider in focus after strong share price run - AD HOC NEWS
DaVita Inc. (DVA) Investor Outlook: Navigating Growth with Robust Returns and Strategic Positioning - DirectorsTalk Interviews
How Investors Are Reacting To DaVita (DVA) Q1 Earnings Beat And Aggressive Share Buybacks - Sahm
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 89/100 - GuruFocus
DaVita stock (US23918K1088): shares stay near 2026 highs after latest pullback - AD HOC NEWS
DaVita Inc. stock (US23918K1088): strong year-to-date rally despite latest pullback in healthcare se - AD HOC NEWS
DaVita Inc (DVA) Stock Up 3.7% but GF Value Says Overvalued -- G - GuruFocus
The 5 Most Interesting Analyst Questions From DaVita’s Q1 Earnings Call - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Does DaVita Insider Equity Move Signal Governance in Russell 1000? - Kalkine Media
DaVita CFO & Treasurer Joel Ackerman Sells 34% Of Holding - simplywall.st
DaVita stock (US23918K1088): TD Cowen raises price target after Q1 earnings - AD HOC NEWS
Insider Sell Alert: David Maughan Sells 20,529 Shares of DaVita Inc (DVA) - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita COO David Maughan sells $4.09 million in company stock By Investing.com - Investing.com South Africa
DaVita(DVA.US) Officer Sells US$4.09 Million in Common Stock - Moomoo
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):